INTRODUCTION
The gastric epithelium is a physiologically self-renewing tissue (Mills and Shivdasani, 2011) . Anatomically, the stomach can be divided into three parts: the forestomach (in mice) or the cardiac region (in humans), the corpus, and the pyloric region. Invaginations from the inner surface called gastric units or glands penetrate deep into the mucosa and contain distinct cell lineages. In the corpus, the main body of the stomach, gastric units are subdivided further into four distinct zones based on the presence of characteristic cell types. Short-lived (2-3 days) surface mucous cells are the main cell type of the uppermost segment, the pit. Directly below the pit, the isthmus contains immature, fast-dividing cells. Below this, the neck region contains mucous neck cells that are thought to transdifferentiate into chief cells in a period of weeks (Goldenring et al., 2011; Mills and Shivdasani, 2011) . Chief cells populate the base and produce digestive enzymes. Scattered throughout all regions are acid-producing parietal cells and rare, hormone-secreting enteroendocrine cells. Chief and parietal cells are long-lived, with an estimated turnover rate of months (Karam and Leblond, 1993a) .
Lineage-tracing studies with chemical mutagenesis (Bjerknes and Cheng, 2002) or genetic tracing from the Sox2 locus (Arnold et al., 2011) have demonstrated the existence of multipotent stem cells in the epithelium. As Sox2-positive (Sox2 + ) cells are scattered throughout the isthmus as well as in lower parts of the gastric unit, it is not clear whether all or only a subset of the Sox2 + cells can induce stem cell-like lineage-tracing events.
Additional markers have been proposed (but not proven by definitive experiments such as, e.g., lineage tracing) for gastric stem cells (Mills and Shivdasani, 2011; Qiao and Gumucio, 2011) . We have recently shown that Lgr5 marks adult stem cells in the pyloric region of the stomach (Barker et al., 2010) . Lgr5 + stem cells express a Wnt target gene program, are located at the bottom of pyloric glands, and are capable of long-term renewal of the epithelium. A second pyloric stem cell has been revealed by lineage tracing with a Villin promoter-driven Cre transgene, which identifies a quiescent stem cell of unknown identity that only becomes apparent upon Interferon-g stimulation (Qiao et al., 2007) . Neither of these two studies identified stem cells in the much larger gastric corpus. Based on the predominant location of proliferative cells in the isthmus of the corpus units, it is generally believed that the isthmus represents the stem cell zone of the corpus epithelium (Karam and Leblond, 1993a) .
RESULTS

Identification of Troy as a Stem Cell Marker in Multiple Adult Tissues
Following the identification of Lgr5 as a marker of adult stem cell populations in small intestine and colon, we have established transcriptional profiles of Lgr5 + stem cells (Muñ oz et al., 2012; van der Flier et al., 2009) . One of the genes that closely followed the expression pattern of Lgr5 in intestinal crypts was Troy (encoded by Tnfrsf19). Troy potentially functions as a receptor for lymphotoxin A (Hashimoto et al., 2008) . It is highly homologous to two other Tnfrsf members, Xedar and Edar. Troy knockout mice are viable and fertile without an obvious phenotype (Shao et al., 2005) . A recent study has confirmed that Troy marks intestinal stem cells (Fafilek et al., 2013) . Interestingly, Troy expression does not correlate with Lgr5 expression in nonintestinal Lgr5 + stem cell populations (Barker et al., 2010; Jaks et al., 2008) . As Troy may mark novel Lgr5-independent sets of adult stem cells, we generated a Troy-eGFP-ires-CreERT2 knockin mouse line (Troy-ki), in which eGFP and CreERT2 are under the control of endogenous Troy-regulatory sequences ( Figure S1A available online). Expression of eGFP occurred in crypt base columnar cells, the Lgr5 + stem cells of the small intestine ( Figure S1B ). In vivo lineage tracing performed in Troy-ki mice crossed with the R26R-LacZ Cre reporter strain resulted in typical ''ribbons,'' confirming recently published data (Fafilek et al., 2013 ) ( Figure S1C ). As expected, lineage tracing was not observed in Lgr5 + stem cell compartments that were Troy negative (Troy À ), i.e., in the colon or gastric pylorus. However, tracing events occurred in the gastric corpus, kidney, liver, lung, and brain. For here, we focused on the gastric corpus.
Troy Is Expressed Specifically at the Base of Gastric Corpus Units Troy-eGFP expression was readily detectable at the base of each gastric corpus unit ( Figures 1A and 1B) , faithfully recapitulating the endogenous expression of Troy. Single-molecule in situ hybridization detected Troy messenger RNA (mRNA) in chief and parietal cells at gland bases, whereas cells of the same types, yet located higher up toward the neck region, were Troy À ( Figure S1D ). Of note, the muscle layer of the stomach also expressed Troy ( Figure 1B , white arrow). Double-immunofluorescent stainings confirmed the expression of Troy-eGFP in chief and parietal cells at the gland base. Troy-eGFP + cells colabeled either with H + K + -ATPase, a marker for parietal cells, or with gastric intrinsic factor (Gif), a marker for chief cells in mice ( Figures 1C and 1D) , whereas the third cell type present at the bottoms of corpus glands, the enteroendocrine cell, was Troy À ( Figure 1E ).
Next, electron microscopy was employed to resolve the ultrastructure of Troy + cells. Cryo-immunogold labeling detected the eGFP marker in both chief and parietal cells at the gland base ( Figure 1F ). Quantification showed an average of 3.9 and 3.5 eGFP-gold particles/1 mm 2 in chief cells and parietal cells, respectively. No eGFP-gold label was detected in the same cell types higher up in the gastric unit or in enteroendocrine cells at the gland bottom (Figures S1E and S1F). The marked cells showed characteristics of mature chief and parietal cells, i.e., extending basal rER cisternae and light homogeneous secretory granules in chief cells and a central nucleus surrounded by the intracellular canaliculus and mitochondria-filled cytoplasm in parietal cells (Karam, 1993; Karam and Leblond, 1993b See also Figure S1 . Withers, 1975; Willems et al., 1972) . We performed triple-immunofluorescent stainings for Ki67 and pepsinogen C together with a membrane marker, and confirmed the existence of rare, dividing chief cells at the bottoms of glands ( Figure S2A ). On average, 3.2% ± 0.78% of corpus glands contained a proliferative cell at the gland base ( Figure S2B ). Thus, despite the fact that the isthmus appears to be the principle zone of proliferation, a second zone with the capability to proliferate exists at the bottom of glands. Eventually, lineage tracing yielded clones of LacZ + cells spanning the entire length of a gland. This was rarely observed at 4 weeks of tracing yet became more frequent from 3 month onward (Figures 2A and 2B ). Of note, no tracing was detected in the pyloric region, consistent with the absence of Troy-eGFP + cells
( Figure 2B Figure S3D ). Furthermore, induction of lineage tracing according to our standard protocol did not result in parietal cell loss, unlike what has been reported in other models (Huh et al., 2012) ( Figure S3E ). Quantification of clone size in tracing clones containing only parietal cells and clones containing chief cells (only chief cells or mixed chief/parietal clones) was performed. Pure parietal cell clones did not grow; the average clone size after 1 week and 3 months was 1.1 and 1.3 ± 0.1 cells, respectively. On the other hand, clones containing chief cells increased in size from an average of 1.9 ± 0.1 to 3.6 ± 0.8 cells/clone at 3 months. This suggested that growth of clones originated from the chief cell population. The position of LacZ + cells was quantified for 100 glands over a 3 month time course ( Figure 2C ). At day 1 p.i., we never detected a LacZ + cell above position 10 from the bottom (this position is still > 10 cell positions below the lower isthmus region). Progressively, the number of LacZ + cells higher up in the gland increased. The clone size was quantified in 100 glands over a 1.5 year time course p.i. An increase in clone size could be observed ( Figure 2D ). The rate of expansion was relatively slow, with an average doubling time of clone size of around 50 days. This fitted well with the observation that chief cells double in 2 months, as analyzed by grain count analysis after 3 H-TdR administration (Willems et al., 1972) .
Within LacZ + ribbons that had grown beyond the isthmus, all differentiated cell types of the gastric corpus were detected, i.e., chief cells, neck cells, parietal cells, proliferating isthmus cells, pit cells, and enteroendocrine cells . We concluded that a Troy + cell with the capacity to generate all stomach epithelial cell types exists at the bottom of glands in the adult gastric corpus. We repeated the tracing experiments using the Cre knockin line Mist1-CreERT2, which is expressed only in mature chief cells (Nam et al., 2010; Shi et al., 2009 ). These mice were crossed with the Rosa-mTmG reporter line ( Figure 3 ). Induction of Cre activity led to the GFP labeling of 1-3 chief cells in the gland base (Figure 3A) . One month later, rare tracing events were observed (Figure 3B) . Traced clones consisted mainly of chief cells and were located at gland bottoms, typically containing at least one cell located at the very base, overlapping with the Troy expression domain ( Figure 3B , arrow). Already within these early tracing units, all principal differentiated cell types of the gastric epithe-
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Mist1-Cre-GFP Mist1-Cre-GFP Mist1-Cre-GFP AAA GSII VEGFB lium were detected ( Figure 3C ). Lineage tracing proceeded as observed for the Troy locus. At 6 months, tracing units spanning entire corpus glands were readily detectable ( Figure 3D ). We first compared our arrays by unsupervised hierarchical clustering to arrays representing the three main lineages of the stomach (pit, parietal, and chief cells) (Ramsey et al., 2007) . The Troy + arrays clustered together with the chief cell array, whereas the pit and parietal cell arrays separated in a different tree ( Figure 4A ). The overall chief cell signature was therefore maintained in the Troy + subpopulation. Troy + chief cells showed enrichment for the chief cell markers Gif and Mist1 ( Figure 4B ). We also detected enrichment in genes previously detected in small intestinal or pyloric stem cells, i.e., Lgr5, Ascl2, Lrig1, and Rnf43/Znrf3 (Barker et al., 2007; Koo et al., 2012; van der Flier et al., 2009; Wong et al., 2012) . In addition to the Wnt target genes Lgr5, Ascl2, and Rnf43/Znrf3, several other well-characterized Wnt target genes were expressed, i.e., Axin2, EphB2, and Cd44 ( Van der Flier et al., 2007) (Figure 4B) . Overall, 113 genes were found to be significant and more than 2-fold enriched in Troy + chief cells compared to whole corpus glands (Table S1 ).
The detection of active Wnt signaling in the adult gastric corpus was surprising, as this pathway has until now only been associated with the pyloric region (Mills and Shivdasani, 2011) . The enrichment of the Wnt signature and intestinal stem cell marker genes in Troy + chief cells was first confirmed by quantitative PCR (qPCR) ( Figure 4C ). Next, we compared the levels of Wnt activity between corpus glands, pylorus, and small intestine by performing qPCR of Axin2 ( Figure 4D ). The overall level of Wnt activity was highest in the small intestine, 10-fold lower in the pylorus, and lowest in corpus glands. The intestinal and pyloric stem cell marker Lgr5 was detected at similar levels in small intestine and corpus, while being highest in the pyloric region. Axin2-LacZ mice (Lustig et al., 2002) showed strong LacZ positivity at the bases of pyloric glands. In addition, these mice revealed Axin2 + cells in the corpus ( Figure 4E ). As the Lgr5-eGFP-ires-CreERT2 mouse (Barker et al., 2007) did not show Lgr5 expression in the corpus region, contrary to our array and qPCR data, we examined expression in an independent Lgr5 reporter, the Lgr5-DTR:eGFP mouse (Tian et al., 2011) . In this line, Lgr5 expression was readily detectable at the bases of corpus glands ( Figure 4F Figures S4A-S4D ). Gene sets for parietal and pit cells were negatively correlated with those for Troy + chief cells ( Figures S4E and S4F ). In summary, the transcriptional program of Troy + chief cells combines chief cell-specific genes with genes previously described as Wnt-dependent stem cell genes.
Single Troy + Chief Cells Can Form Long-Lived Organoids that Differentiate toward Mucus Neck and Pit Cells We have previously established a long-term culture system that allows unlimited expansion from single Lgr5 + pyloric stem cells (Barker et al., 2010) . To test whether similar epithelial organoid cultures can be established from the corpus epithelium, we attempted to culture freshly isolated, entire corpus units. Within a few hours after seeding, the units disaggregated. Subsequently, rare cells typically located at the bottom of the gland units started to proliferate and form cystic structures ( Figure 5A ). To investigate whether the cultures were derived from Troy + cells, we induced tracing in vivo in Troy-ki crossed with Rosa-YFP Cre reporter mice 3 days before the isolation of glands. We then followed the expression of YFP in the developing organoids in vitro. Initially, YFP and GFP signals overlapped ( Figure 5B ). In the course of a week, the YFP-tracing clones continuously expanded, contributing significantly to the cell mass of growing organoids ( Figure 5C ).
We next tested whether single Troy + cells isolated from gastric units of the corpus were also capable of generating organoids. Two populations of Troy + cells, different in scatter properties, were observed with FACS ( Figure 6A ). Stainings for lineage markers on sorted cells showed that the ''small cell'' population (gate A) consisted of chief cells, whereas the population containing larger cells (gate B) represented parietal cells ( Figure 6B ). Troy + chief cells consistently grew out into organoids (colonyforming efficiency 5.4%) ( Figure 6C ). We followed a single sorted chief cell over a period of 6 month, by weekly passaging at a 1:6 ratio ( Figure 6D ). No change in growth behavior was apparent over the culture period. Similarly, single sorted Mist1 + chief cells could initiate organoid growth (Figures S5A and S5B) . In contrast, Troy + parietal cells died within 1-2 days of culture (Figure 6C) . Immunohistochemistry (IHC) demonstrated a high proliferative activity of Troy + -derived organoids ( Figure 6E ). Double stainings revealed the presence of proliferative chief cells (Figure 6F) . Besides chief cells, we noted a distinct population of cells expressing the epitope for GSII, a marker for mucus neck cells ( Figure 6G) . A similar expression pattern of mucous neck, chief, and proliferation markers has been described in a twodimensional (2D) chief cell culture (Tashima et al., 2009) .
A small proportion of Troy À cells (0.4%) was also able to generate corpus organoids ( Figure 6C ). Although occasional tracings spanning entire gastric units could be found within 1 month p.i., most tracings progressed slowly (Figures 2A and S3C ). Proliferating chief cells were rare in the bottom part of glands ( Figures S2A and S2B ), whereas the isthmus region was constantly cycling ( Figure 7A ). Troy + stem cells therefore appeared largely dispensable for physiological renewal of the corpus epithelium, rather acting like a ''reserve'' stem cell population.
To test this hypothesis, we used 5-fluoruracil (5-FU) to selectively kill the proliferative cells in the gastric corpus. This approach has been successfully employed in the bone marrow (Lerner and Harrison, 1990) . We induced tracing by tamoxifen administration followed by injection of a single dose of 5-FU 3 days later in the treatment (but not the control) group (Figure 7K) . A single dose of 150 mg/kg was enough to completely abolish proliferation in the corpus epithelium ( Figure 7D ) 2 days post 5-FU injection, whereas Troy + cells, consistent with their slowly cycling nature, appeared unaffected ( Figures 7B and  7E ). We did not detect any significant change in the composition of the other lineages ( Figure S3E ). Apoptosis was mainly observed in the isthmus region ( Figures 7C and 7F ).
The first sign of a contribution of Troy + chief cells to regeneration after 5-FU was seen after 7 days. The percentage of glands with proliferating, Ki67 + cells at the gland bottom increased 3-fold from 3.2% ± 0.8% to 10.5% ± 0.9% ( Figure S2B ). Cellcycle dynamics at the gland bottom were further analyzed with a double thymidine-analog label-retention experiment. Administration of BrdU (2 weeks of labeling followed by a 3 week chase) and EdU (three times within 6 hr before sacrifice) resulted in BrdUretaining cells at the gland bottoms ( Figure S2C ). These cells could be induced to proliferate again upon 5-FU damage, resulting in BrdU;Edu double-positive cells ( Figure S2C , right panel). Dividing gland bottom cells therefore can re-enter the cell cycle. Four weeks after 5-FU treatment, accelerated expansion of LacZ + clones was evident ( Figures 7G-7J ). The number of tracing events that reached the gastric lumen increased 6-fold after 5-FU treatment, as compared to the untreated controls ( Figure 7H, iii and 7I) . Quantification of the size of tracing units clearly showed a shift toward larger units in 5-FU-treated mice ( Figure 7J ).
DISCUSSION
In this study, we assess Troy as a marker of cells that contribute to tissue renewal in the gastric corpus. We find that Troy is expressed by a small subset of chief cells and parietal cells located at the gland base. Under steady-state conditions, these cells phenotypically fulfill all requirements of differentiated cells. It was recognized 40 years ago that rare cells with chief cell characteristics and located at the bottom of corpus glands can incorporate radiolabeled thymidine (Chen and Withers, 1975; Willems et al., 1972 See also Figure S4 and Table S1 . partial hepatectomy and resume cell division (Fausto, 2000; Michalopoulos and DeFrances, 1997) . Adult Schwann cells have recently been shown to possess a degree of plasticity. When infected with leprosy bacilli, differentiated Schwann cells are induced to convert toward a mesenchymal progenitor/stemlike phenotype (Masaki et al., 2013) . cultures that can be differentiated toward the mucus-producing cell lineages of the neck and pit in vitro. Their slowly cycling nature as well as their potential to be activated upon selective killing of the highly proliferative isthmus cells are reminiscent of quiescent/''reserve'' tissue stem cells (Li and Clevers, 2010 (Arnold et al., 2011) . We observed that almost all epithelial cells within the normal stomach as well as in the organoids express Sox2 ( Figure S6 ). We also do see clear expression of Sox2 in Troy + chief cells in our array data with no difference compared to whole corpus glands (p = 0.41). Within the isthmus, Tff2-expressing cells have been demonstrated to represent progenitors of chief and parietal cells, but not of mucous-secreting pit cells and enteroendocrine cells (Quante et al., 2010) . Besides the immediate labeling of parietal cells, Tff2-driven lineage tracing results in the labeling of mucous neck cells andlater-in the labeling of chief cells. This delay agrees with the view that chief cells can be generated by transdifferentiation of mucous neck cells (Goldenring et al., 2011) . Although this has not been unequivocally proven by lineage tracing of mucous neck cells, substantial indirect evidence exists to support this concept (Goldenring et al., 2011) . This evidence is based on findings that, first, nucleotide analogs after administration are initially seen in mucous neck cells and only afterward in chief cells (Karam and Leblond, 1993b) . Second, the deletion of the chief cell transcription factor Mist1 or its upstream transcriptional regulator Xbp1 results in the accumulation of cells with mixed chief-neck cell characteristics, whereas neck cells are normal, indicating a block in transdifferentiation (Bredemeyer et al., 2009; Huh et al., 2010; Ramsey et al., 2007) . The current finding might constitute a reversion of this process, a retransformation into mucous neck cells and then into isthmus cells.
In accordance with our observation of Troy + chief cell activation upon 5-FU treatment is the fact that chief cells at the bottom of glands can be activated upon the specific loss of parietal cells (Bredemeyer et al., 2009; Nomura et al., 2004) . Such loss leads to the generation of a metaplastic cell lineage derived from chief cells, called SPEM (spasmolytic polypeptide-expressing metaplasia) (Nam et al., 2010) . This activation of chief cells is another example of the capacity of mature chief cells to re-enter the cell cycle. The generation of the SPEM cell lineage can also be seen as a reverse transformation of chief cells toward mucous neck cells, as the SPEM lineage expresses markers of both lineages (Capoccia et al., 2013) . Chief cells thus react upon damage with proliferation and with changes in their differentiation state. Our lineage-tracing-based observations of stem cell-like behavior of chief cells might thus constitute a physiological equivalent of the SPEM process. What might explain this unusual phenomenon? The proposed location of the more active, ''workhorse'' stem cell population in the isthmus is unique compared to other stem cell niches in the gastrointestinal tract. The stem cells of the pylorus, small intestine, and colon all reside at the bottoms of epithelial invaginations, farthest away from the potentially harmful contents of the lumen. The isthmus is thus less well protected against damaging agents. A quiescent stem-like cell, such as the Troy + chief cell at the bottom, might serve as back-up to a vulnerable, active stem cell niche located closer to the lumen. Taken together, Troy + chief cells at gland bottoms can serve as quiescent stem-like cells in the epithelium of the gastric corpus. As has been proposed for other self-renewing tissues (Li and Clevers, 2010) , the gastric corpus thus appears to contain two stem cell populations: an actively dividing population located in the isthmus (that remains to be specifically identified) and a small population of ''reserve'' stem-like chief cells, marked by Troy, at the gland base. The unique property of the Troy + cell as a fully differentiated cell with the capability to act as a multipotent stem cell represents a surprising example of plasticity in epithelial stem cell biology.
EXPERIMENTAL PROCEDURES
Details on procedures can be found in the Extended Experimental Procedures.
Mice and Treatments
Troy-ki mice were generated by homologous recombination in embryonic stem cells targeting an eGFP-ires-CreERT2 cassette at the translational start site of Tnfrsf19 ( Figure S1A ). Cre-recombinase was activated in Troy-ki +/ki ;RosaLacZ , 2007) . Tamoxifen (1 mg/20 g; Sigma) was injected intraperitoneally every other day for a week (three injections total) to induce GFP induction.
Confocal Analysis of eGFP Expression in Near-Native Tissue Sections Vibratome sections were prepared from Troy-ki and Lgr5-DTR:eGFP stomachs and analyzed by confocal microscopy for eGFP expression.
Single-Molecule mRNA In Situ Hybridization
Single-molecule mRNA in situ hybridization was performed as described before (Raj et al., 2008) . Probe libraries consisted of typically 48 probes with 20 bp of length complementary to the coding sequence.
Detection of b-Galactosidase Activity and Quantification Detection of b-galactosidase was performed by X-Gal staining. One hundred gastric units were counted, and the positions of LacZ + cells from the bottom of glands were noted 1 day, 1 month, and 3 months p.i. Quantification of LacZ + clone size was performed in 100 gastric units at 1 day, 1 month, 3 months, and 1.5 years p.i. For the number of tracings that reached the lumen, LacZ + clones in ten adjacent sections were counted.
IHC and Confocal Imaging
Paraffin and cryosections were prepared according to standard protocols. For primary and secondary antibody details, see the Extended Experimental Procedures. Mist1-CreERT2 tracings were imaged with either Apotome 2 optical sectioning on a Zeiss Axiovert or a custom-built two-photon microscope (Kao et al., 2010) .
Immunoelectron Microscopy GFP expression was detected using cryo-immuno gold staining (Peters et al., 2006) . 
Gastric Unit Isolation and FACS
Gastric Corpus Organoid Culture
Whole gastric glands, FACS-isolated single Troy-eGFP + chief or parietal cells, and Mist1-eGFP + cells were cultured in Matrigel using EGF, Gastrin, FGF10, Noggin, Wnt3a, and R-spondin supplemented culture medium (ENRGFW medium) and passaged weekly. Differentiation toward the pit cell lineage was induced by growing the organoids in Fgf10-, Noggin-, and Wnt-free medium (ERG medium). Tamoxifen was added to the culture medium to induce in vitro lineage tracing. YFP and eGFP were subsequently visualized and recorded in live organoids with confocal microscopy (Leica, SP5).
BrdU and EdU Labeling
BrdU labeling was administered with osmotic pumps. Edu was injected 6, 4, and 2 hr before sacrifice. Paraffin sections were stained with an anti-BrdU antibody, EdU detected by a Click-iT reaction, and sections visualized by confocal microscopy.
Microarray Analysis
Expression profiling was performed on Affymetrix chips with sorted Troy + chief cells (gate A in Figure 6 ), whole corpus glands, and organoids grown in either ENRGFW or ERG medium and analyzed with the R2 web application (http://r2.amc.nl).
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Array data are available at Gene Expression Omnibus (GEO) under the accession number GSE44060. 
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